TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect
- PMID: 20036814
- DOI: 10.2741/3614
TGF-beta signaling, tumor microenvironment and tumor progression: the butterfly effect
Abstract
Transforming growth factor-beta (TGF-beta) signals through receptor serine/threonine kinases and intracellular Smad effectors, regulating numerous epithelial cell processes. TGF-beta plays a crucial role in the cancer initiation and progression through tumor cell autonomous signaling and interactions with tumor microenvironment, but is featured with a butterfly effect upon the stages of tumorigenesis. TGF-beta signaling acts as a suppressor of epithelial cell tumorigenesis at early stages, but promotes tumor progression by enhancing migration, invasion, and survival of the tumor cells during the later stages. TGF-beta signaling also cross-talks with other cell survival signaling pathways. Tumor microenvironment contains many distinct cell types, which substantially influences the tumor cell growth and survival, and the invasion and metastasis. TGF-beta in the microenvironment, produced by cancer and/or stromal cells, is high and negatively correlates with disease progression and patient prognosis. Therefore, TGF-beta may affect tumor progression by multiple mechanisms in addition to its direct action on tumor cells, and the diversities of TGF-beta signaling in tumors imply a need for caution to TGF-beta-targeted strategies of tumor prevention and/or therapeutics.
Similar articles
-
Lack of transforming growth factor-β signaling promotes collective cancer cell invasion through tumor-stromal crosstalk.Breast Cancer Res. 2012 Jul 2;14(4):R98. doi: 10.1186/bcr3217. Breast Cancer Res. 2012. PMID: 22748014 Free PMC article.
-
TGF-beta and immune cells: an important regulatory axis in the tumor microenvironment and progression.Trends Immunol. 2010 Jun;31(6):220-7. doi: 10.1016/j.it.2010.04.002. Epub 2010 Jun 1. Trends Immunol. 2010. PMID: 20538542 Free PMC article. Review.
-
Transforming Growth Factor-β1 in Cancer Immunology: Opportunities for Immunotherapy.Adv Exp Med Biol. 2023;1408:309-328. doi: 10.1007/978-3-031-26163-3_17. Adv Exp Med Biol. 2023. PMID: 37093435 Review.
-
Transforming growth factor-β in tumor microenvironment: Understanding its impact on monocytes and macrophages for its targeting.Int Rev Immunol. 2025;44(2):82-97. doi: 10.1080/08830185.2024.2411998. Epub 2024 Oct 8. Int Rev Immunol. 2025. PMID: 39377520 Review.
-
Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.Cancer Res. 2008 Mar 15;68(6):1809-19. doi: 10.1158/0008-5472.CAN-07-5597. Cancer Res. 2008. PMID: 18339861
Cited by
-
The role of transforming growth factor-beta in suppression of hepatic metastasis from colon cancer.HPB (Oxford). 2010 Sep;12(7):498-506. doi: 10.1111/j.1477-2574.2010.00219.x. HPB (Oxford). 2010. PMID: 20815859 Free PMC article.
-
Reactive oxygen species-mediated PKC and integrin signaling promotes tumor progression of human hepatoma HepG2.Clin Exp Metastasis. 2011 Dec;28(8):851-63. doi: 10.1007/s10585-011-9416-6. Epub 2011 Aug 14. Clin Exp Metastasis. 2011. PMID: 21842414
-
Polyploid giant cancer cells, cytokines and cytomegalovirus in breast cancer progression.Cancer Cell Int. 2023 Jun 20;23(1):119. doi: 10.1186/s12935-023-02971-1. Cancer Cell Int. 2023. PMID: 37340387 Free PMC article.
-
SIRT1 facilitates hepatocellular carcinoma metastasis by promoting PGC-1α-mediated mitochondrial biogenesis.Oncotarget. 2016 May 17;7(20):29255-74. doi: 10.18632/oncotarget.8711. Oncotarget. 2016. PMID: 27081083 Free PMC article.
-
Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells.Prostate. 2018 Apr;78(5):377-389. doi: 10.1002/pros.23482. Epub 2018 Jan 16. Prostate. 2018. PMID: 29341212 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources